Neutrophil to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular outcomes in subjects with pre-diabetes: a large cohort study from China
- PMID: 36057713
- PMCID: PMC9441053
- DOI: 10.1186/s12944-022-01695-x
Neutrophil to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular outcomes in subjects with pre-diabetes: a large cohort study from China
Abstract
Background: This study aimed to examine whether the neutrophil to high-density lipoprotein cholesterol ratio (NHR) can predict cardiovascular outcomes in normoglycemic individuals with elevated fasting glucose levels.
Methods: A total of 130,801 participants with normal blood glucose levels were enrolled in the Kailuan study. Participants were categorized according to NHR quartiles and further divided into normal glucose regulation (NGR) and pre-diabetes (pre-DM) subgroups. The follow-up endpoint was major adverse cardiovascular events (CVE), including stroke and myocardial infarction.
Results: Over a median of 12.53 (8.95-13.08) years of follow-up, subjects with NHR levels in the highest quartile experienced more CVE than those with NHR levels in the lowest quartile. Multivariate Cox analyses showed that continuous changes in NHR (hazard ratio, 1.21; 95% confidence interval [CI], 1.15-1.28) and the highest quartile of NHR (hazard ratio, 1.30; 95% CI, 1.21-1.39) were independent predictors of CVE (all P < 0.001). Furthermore, when participants were categorized by both NHR quartile and glucose metabolism status, the NHR level in the highest quartile plus pre-DM group was associated with a 1.60-fold (95% CI, 1.38-1.86; P < 0.001] higher risk of CVE than that in the lowest quartile plus normoglycemic group. Significantly, the addition of NHR only, presence of pre-DM only, or combination of NHR and pre-DM to the prediction algorithm, including traditional risk factors, improved the C-statistic by 0.19, 0.05, and 0.23 (all P < 0.001).
Conclusions: Elevated NHR or fasting blood glucose level were independently associated with a higher risk of CVE among normoglycemic individuals. Moreover, pre-DM participants with high NHR levels tended to have worse prognosis, suggesting that NHR could provide greater risk stratification value than traditional risk factors for subjects with pre-DM.
Keywords: Fasting blood glucose; Neutrophil to HDL ratio; Pre-diabetes; Prognosis.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
The Association of Systemic Inflammatory Response Index and Neutrophil-to-High-Density Lipoprotein Ratio Mediated by Fasting Blood Glucose with 90-Day Prognosis in Acute Ischemic Stroke Patients.Neuroepidemiology. 2025;59(1):31-42. doi: 10.1159/000539132. Epub 2024 May 15. Neuroepidemiology. 2025. PMID: 38749405 Free PMC article.
-
Neutrophil to high-density lipoprotein ratio associates with higher all-cause mortality and new onset cardiovascular events in peritoneal dialysis patients.Int Urol Nephrol. 2022 Oct;54(10):2745-2754. doi: 10.1007/s11255-022-03202-8. Epub 2022 Apr 12. Int Urol Nephrol. 2022. PMID: 35411415
-
Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.Cardiovasc Diabetol. 2020 Mar 19;19(1):36. doi: 10.1186/s12933-020-01012-9. Cardiovasc Diabetol. 2020. PMID: 32192491 Free PMC article.
-
Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes.Diabetes Care. 2019 Jul;42(7):1312-1318. doi: 10.2337/dc19-0274. Epub 2019 May 10. Diabetes Care. 2019. PMID: 31076417
-
Utility of neutrophil-to-high-density lipoprotein-cholesterol ratio in patients with coronary artery disease: a narrative review.J Int Med Res. 2023 Apr;51(4):3000605231166518. doi: 10.1177/03000605231166518. J Int Med Res. 2023. PMID: 37038922 Free PMC article. Review.
Cited by
-
Comprehensive predictive model for cerebral microbleeds: integrating clinical and biochemical markers.Front Neurosci. 2024 Dec 13;18:1429088. doi: 10.3389/fnins.2024.1429088. eCollection 2024. Front Neurosci. 2024. PMID: 39734492 Free PMC article.
-
Lipid metabolism-related inflammatory indices (LMIIs) and incident peripheral artery diseases (PAD) in patients with type 2 diabetes mellitus (T2DM): a multicohort study from China and the UK biobank.Cardiovasc Diabetol. 2025 Aug 22;24(1):346. doi: 10.1186/s12933-025-02887-2. Cardiovasc Diabetol. 2025. PMID: 40847315 Free PMC article.
-
Prognostic Value of Neutrophil, Monocyte, Lymphocyte, and Platelet/High-Density Lipoprotein Ratios in Ischemic Heart Disease: An NHANES Analysis.Medicina (Kaunas). 2024 Dec 19;60(12):2084. doi: 10.3390/medicina60122084. Medicina (Kaunas). 2024. PMID: 39768963 Free PMC article.
-
NPR is an independent risk factor for predicting all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease: evidence from NHANES 2007-2020.Popul Health Metr. 2025 Apr 25;23(1):15. doi: 10.1186/s12963-025-00378-w. Popul Health Metr. 2025. PMID: 40281626 Free PMC article.
-
The Association Between Neutrophil/High-Density Lipoprotein Cholesterol Ratio and Non-Alcoholic Fatty Liver Disease in a Healthy Population.Diabetes Metab Syndr Obes. 2024 Jun 26;17:2597-2605. doi: 10.2147/DMSO.S464406. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38946914 Free PMC article.
References
MeSH terms
Substances
Grants and funding
- No. 2021-1-I2M-007/CAMS Innovation Fund for Medical Sciences
- No. 2021-1-I2M-007/CAMS Innovation Fund for Medical Sciences
- No. 81825002/National Natural Science Foundation of China
- No. 81825002/National Natural Science Foundation of China
- No. BJJWZYJH01201910023029/Beijing Outstanding Young Scientist Program
- No. BJJWZYJH01201910023029/Beijing Outstanding Young Scientist Program
- No. Z191100006619106/Capital Clinical Diagnosis and Treatment Technology Research and Demonstration Application Project of Beijing Science and Technology Commission
- No. Z191100006619106/Capital Clinical Diagnosis and Treatment Technology Research and Demonstration Application Project of Beijing Science and Technology Commission
- No. Z201100005620006/AI+ Health Collaborative Innovation Cultivation Project of Beijing Science and Technology Commission
- No. Z201100005620006/AI+ Health Collaborative Innovation Cultivation Project of Beijing Science and Technology Commission
LinkOut - more resources
Full Text Sources
Medical